RYM
RYM FPO NZX [RYM]
Healthcare · ASX Small Cap
$1.8000 +2.3%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical62
Catalyst57
Sentiment50
Fundamental71
Momentum40
Risk Gate39
Get alerts when RYM's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- Stochastic just turned bullish from a low level — early reversal sign
- Sitting near support — this level has held before and could attract buyers again
- Drifting lower — down 3.5% over the last 5 days
- Cash positive / operating cashflow positive
- Low P/S ratio (2.3x)
- Moderate revenue growth (+13%)
- Near 52-week low (0% of range)
- Substantial holder(s) ceased (1)
- CANSLIM I: Institutional ownership (25%)
- Sentiment is mixed — no strong consensus either way
- Altman Z-Score distress zone (0.89 < 1.81, low-confidence approx)
- Serial restatements detected (2 corrections/amendments)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Deeply negative margins (-70%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.41%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about RYM
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Deed of Amendment relating to Master Trust Deed
NONE Amendments to Bond Trust Deed
NONE 2026 Investor Day Recording
HIGH Ceasing to be a substantial holder
Announcement tone +5pts
Recent ASX Announcements
| 2026-03-18 | Deed of Amendment relating to Master Trust Deed |
| 2026-03-18 | Amendments to Bond Trust Deed |
| 2026-02-24 | Ceasing to be a substantial holder |
| 2026-02-03 | 2026 Investor Day Recording |
| 2026-02-03 | Investor Day 2026 Presentation PRICE SENSITIVE |
Key Metrics
$1.8B
Market Cap
24K
Avg Volume
1.5x
Vol Ratio
$1.81 — $2.64
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-13.4%
ROE
-69.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 97% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | pass | Inst: 25% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #92 of 117 · Sector avg: 46
View all Healthcare signals →Track RYM and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required